Stock ASTERDM ASTER DM HEALTHCARE LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Aster DM Healthcare Limited

Equities

ASTERDM

INE914M01019

Market Closed - NSE India S.E.
Other stock markets
 07:43:46 2024-04-26 EDT 		5-day change 1st Jan Change
358.8 INR -1.95% Intraday chart for Aster DM Healthcare Limited -31.07% -12.43%
04-26 Aster DM Healthcare Names CFO MT
04-25 Aster DM Healthcare Limited Announces Resignation of Amitabh Johri as A Key Managerial Personnel CI

Strengths

  • The earnings growth currently anticipated by analysts for the coming years is particularly strong.
  • Over the last twelve months, the sales forecast has been frequently revised upwards.
  • Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
  • Over the past four months, analysts' average price target has been revised upwards significantly.
  • The opinion of analysts covering the stock has improved over the past four months.
  • Considering the small differences between the analysts' various estimates, the group's business visibility is good.
  • The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.

Weaknesses

  • With an expected P/E ratio at 42.98 and 24.36 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
  • The company appears highly valued given the size of its balance sheet.
  • The company is not the most generous with respect to shareholders' compensation.
  • For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
  • For the last few months, analysts have been revising downwards their earnings forecast.
  • The company's earnings releases usually do not meet expectations.

Ratings chart - Surperformance

Sector: Healthcare Facilities & Services

1st Jan change Capi. Investor Rating ESG Refinitiv
ASTER DM HEALTHCARE LIMITED Stock Aster DM Healthcare Limited
-12.43% 2.14B -
AIER EYE HOSPITAL GROUP CO., LTD. Stock Aier Eye Hospital Group Co., Ltd.
-20.16% 16.21B
B+
BANGKOK DUSIT MEDICAL SERVICES Stock Bangkok Dusit Medical Services
+4.50% 12.44B
B
IHH HEALTHCARE Stock IHH Healthcare
+3.98% 11.58B
B+
APOLLO HOSPITALS ENTERPRISE LIMITED Stock Apollo Hospitals Enterprise Limited
+9.72% 10.79B
B+
RAMSAY HEALTH CARE LIMITED Stock Ramsay Health Care Limited
-2.19% 7.68B
A-
MOUWASAT MEDICAL SERVICES COMPANY Stock Mouwasat Medical Services Company
+18.43% 7.2B
D
THE ENSIGN GROUP, INC. Stock The Ensign Group, Inc.
+4.49% 6.67B
B-
GLOBAL HEALTH LIMITED Stock Global Health Limited
+50.89% 4.66B -
DALLAH HEALTHCARE COMPANY Stock Dallah Healthcare Company
-5.12% 4.25B -
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. ASTERDM Stock
  4. Ratings Aster DM Healthcare Limited